Rupei Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rupei Tang has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
Xin Wang
Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences
61 shared publicationsJun Wang
Anhui Univ, Engn Res Ctr Biomed Mat, Sch Life Sci, 111 Jiulong Rd, Hefei 230601, Anhui, Peoples R China
31 shared publicationsXu Cheng
28 shared publicationsGuoqing Yan
Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, 111 Jiulong Road, Hefei, Anhui Province 230601, PR China
24 shared publicationsJiaxi Xu
Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, 111 Jiulong Road, Hefei, Anhui Province 230601, PR China
13 shared publicationsLe He
Engineering Research Center for Biomedical Materials, School of Life Science, Anhui Key Laboratory of Modern Biomanufacturing, Anhui University, 111 Jiulong Road, Hefei, Anhui Province, 230601, PR China
13 shared publications
Latest Publications
- 27 October 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (22) , 10920-10931
Construction of pH-Sensitive Dynamic Composite Hydrogels and Their Local Targeted Antitumor Research
The treatment of solid tumors is often limited by traditional methods such as surgery and chemotherapy. These methods potentially kill cancer cells but cause significant systemic toxicity and tissue damage. This research introduces a pH-responsive injectable hydrogel (named as Gel-FOEDS) containing fluorinated ortho-ester-loaded dasatinib (DAS) and sunitinib (SUN) and provides a potential strategy to overcome certain limitations of traditional therapies. This gel acts as a “drug pool” that delivers, penetrates, and retains drugs—enabling sustained, deep tumor delivery. Studies have shown that FOE can carry DAS and SUN to escape from the hydrogel rapidly and penetrate deep into the tissue. The imine bond's acid instability in the hydrogel and FOE's specific response to the acidic microenvironment work together for targeted, controllable release of DAS and SUN at the tumor site. The self-assembly of DAS and SUN forms nanoparticles (NPs), which prolongs their retention in tumor tissues. In the mouse solid tumor model, the Gel-FOEDS group demonstrated the strongest antitumor activity, with some tumor-bearing mice achieving complete tumor regression. Our results indicate this composite hydrogel provides an efficient local delivery solution for tyrosine kinase inhibitors (TKIs) and offers a low-side-effect strategy for the treatment of solid tumors.
- 27 October 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (22) , 10920-10931
Construction of pH-Sensitive Dynamic Composite Hydrogels and Their Local Targeted Antitumor Research
The treatment of solid tumors is often limited by traditional methods such as surgery and chemotherapy. These methods potentially kill cancer cells but cause significant systemic toxicity and tissue damage. This research introduces a pH-responsive injectable hydrogel (named as Gel-FOEDS) containing fluorinated ortho-ester-loaded dasatinib (DAS) and sunitinib (SUN) and provides a potential strategy to overcome certain limitations of traditional therapies. This gel acts as a “drug pool” that delivers, penetrates, and retains drugs—enabling sustained, deep tumor delivery. Studies have shown that FOE can carry DAS and SUN to escape from the hydrogel rapidly and penetrate deep into the tissue. The imine bond's acid instability in the hydrogel and FOE's specific response to the acidic microenvironment work together for targeted, controllable release of DAS and SUN at the tumor site. The self-assembly of DAS and SUN forms nanoparticles (NPs), which prolongs their retention in tumor tissues. In the mouse solid tumor model, the Gel-FOEDS group demonstrated the strongest antitumor activity, with some tumor-bearing mice achieving complete tumor regression. Our results indicate this composite hydrogel provides an efficient local delivery solution for tyrosine kinase inhibitors (TKIs) and offers a low-side-effect strategy for the treatment of solid tumors.
- 6 August 2026
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (9) , 4819-4832
Efficient Antimicrobial Nanoenzymatic Functionalized Hydrogels for Diabetic Infected Wound Treatment
The high glycemic environment of diabetic wounds predisposes to bacterial infections that seriously threaten the wound healing process. Therefore, inhibition of bacterial infection and remodeling of the wound microenvironment are crucial for the healing of diabetic infected wounds. In this study, gold nanoparticles (Au NPs) and glucose oxidase (GOx) were loaded in situ onto the surface of zeolitic imidazolate framework-8 nanoparticles (ZIF-8 NPs) to prepare ZIF-8@Au@GOx (ZAG) nanoenzymes. It catalyzed the production of glucuronic acid and H2O2 from glucose, lowered the wound pH, promoted the release of Zn2+, and catalyzed the production of hydroxyl radicals (·OH) from H2O2, thus serving to regulate the wound microenvironment, reducing glucose levels, and providing efficient antimicrobial activity. Subsequently, the nanoenzymes were loaded into β-cyclodextrin-based host–guest interaction and perylene-bonded tandem highly dynamic adaptive (DSA) hydrogels to obtain nanoenzyme-functionalized hydrogels (ZAG@Gel). The hydrogel could adapt to the shape of the wound, effectively fit the damaged skin, and play a role in reducing the toxicity and slowing down the release. In vitro studies showed that ZAG@Gel could release ZAG nanoenzymes in situ, causing the bacterial surface to crumple, the cell membrane structure to be disrupted, and the internal substances to be leaked. In vivo animal experiments showed that the wound healing rate after ZAG@Gel treatment reached nearly 98.06%. Thus, this highly effective antibacterial nanoenzyme-functionalized hydrogel has a strong bactericidal ability and shows good pro-diabetic infected wound healing properties.
- 6 August 2026
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 12 (9) , 4819-4832
Efficient Antimicrobial Nanoenzymatic Functionalized Hydrogels for Diabetic Infected Wound Treatment
The high glycemic environment of diabetic wounds predisposes to bacterial infections that seriously threaten the wound healing process. Therefore, inhibition of bacterial infection and remodeling of the wound microenvironment are crucial for the healing of diabetic infected wounds. In this study, gold nanoparticles (Au NPs) and glucose oxidase (GOx) were loaded in situ onto the surface of zeolitic imidazolate framework-8 nanoparticles (ZIF-8 NPs) to prepare ZIF-8@Au@GOx (ZAG) nanoenzymes. It catalyzed the production of glucuronic acid and H2O2 from glucose, lowered the wound pH, promoted the release of Zn2+, and catalyzed the production of hydroxyl radicals (·OH) from H2O2, thus serving to regulate the wound microenvironment, reducing glucose levels, and providing efficient antimicrobial activity. Subsequently, the nanoenzymes were loaded into β-cyclodextrin-based host–guest interaction and perylene-bonded tandem highly dynamic adaptive (DSA) hydrogels to obtain nanoenzyme-functionalized hydrogels (ZAG@Gel). The hydrogel could adapt to the shape of the wound, effectively fit the damaged skin, and play a role in reducing the toxicity and slowing down the release. In vitro studies showed that ZAG@Gel could release ZAG nanoenzymes in situ, causing the bacterial surface to crumple, the cell membrane structure to be disrupted, and the internal substances to be leaked. In vivo animal experiments showed that the wound healing rate after ZAG@Gel treatment reached nearly 98.06%. Thus, this highly effective antibacterial nanoenzyme-functionalized hydrogel has a strong bactericidal ability and shows good pro-diabetic infected wound healing properties.
- 15 July 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (14) , 9180-9193
Injectable and Wet-Adhesive Coacervate with Enhanced Photothermal Properties for Localized Tumor Treatment
- 15 July 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (14) , 9180-9193
Injectable and Wet-Adhesive Coacervate with Enhanced Photothermal Properties for Localized Tumor Treatment
- 20 June 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 255, 114896
pH-triggered small molecule theranostic nanodrug mediates selective tumor CT imaging and chemotherapy
- 20 June 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 255, 114896
pH-triggered small molecule theranostic nanodrug mediates selective tumor CT imaging and chemotherapy
- 11 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (7) , 5854-5868
pH-Responsive Nanosuspension Based on an Orthoester for Synergistic Chemodynamic and Photothermal Therapy in Localized Cancer Treatment
This study aims to develop a pH-responsive nanosuspension for localized cancer therapy by integrating photothermal therapy (PTT) and chemodynamic therapy (CDT). Initially, we synthesized a compound containing two five-membered cyclic orthoester bonds (OE) as a liquid pharmaceutical excipient. This OE was subsequently coloaded with the photothermal agent indocyanine green (ICG) and iron oxide nanoparticles (Fe3O4), forming a stable nanosuspension (OE/ICG/Fe3O4). OE exhibits acid-sensitive degradation, enabling controlled drug release in the tumor microenvironment. The Fe3O4 nanoparticles can induce the generation of reactive oxygen species (ROS) through the Fenton reaction, which synergizes effectively with the photothermal effect of ICG. Additionally, the OE/ICG/Fe3O4 formulation prolongs drug retention in tumor tissues and enhances drug penetration. Furthermore, the formulation induces immune modulation via Fe3O4, thereby enhancing the overall therapeutic efficacy. Under 808 nm near-infrared laser irradiation, a tumor suppression rate of 84.6% was achieved through the combination of photothermal and chemodynamic therapies and immunotherapy. This study highlights the potential of OE-based nanosuspensions for localized cancer treatment, offering a multifunctional strategy to improve treatment outcomes while minimizing systemic toxicity.
- 11 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (7) , 5854-5868
pH-Responsive Nanosuspension Based on an Orthoester for Synergistic Chemodynamic and Photothermal Therapy in Localized Cancer Treatment
This study aims to develop a pH-responsive nanosuspension for localized cancer therapy by integrating photothermal therapy (PTT) and chemodynamic therapy (CDT). Initially, we synthesized a compound containing two five-membered cyclic orthoester bonds (OE) as a liquid pharmaceutical excipient. This OE was subsequently coloaded with the photothermal agent indocyanine green (ICG) and iron oxide nanoparticles (Fe3O4), forming a stable nanosuspension (OE/ICG/Fe3O4). OE exhibits acid-sensitive degradation, enabling controlled drug release in the tumor microenvironment. The Fe3O4 nanoparticles can induce the generation of reactive oxygen species (ROS) through the Fenton reaction, which synergizes effectively with the photothermal effect of ICG. Additionally, the OE/ICG/Fe3O4 formulation prolongs drug retention in tumor tissues and enhances drug penetration. Furthermore, the formulation induces immune modulation via Fe3O4, thereby enhancing the overall therapeutic efficacy. Under 808 nm near-infrared laser irradiation, a tumor suppression rate of 84.6% was achieved through the combination of photothermal and chemodynamic therapies and immunotherapy. This study highlights the potential of OE-based nanosuspensions for localized cancer treatment, offering a multifunctional strategy to improve treatment outcomes while minimizing systemic toxicity.
- 31 May 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 254, 114841
Injectable nanosuspension based on orthoester for synergistic chemo-photothermal/gas therapy in localized cancer treatment
- 31 May 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 254, 114841
Injectable nanosuspension based on orthoester for synergistic chemo-photothermal/gas therapy in localized cancer treatment
- 11 March 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (11) , 7546-7558
Antibacterial Chitin-Based Sponges with Enhanced Water Absorbency and Mechanical Properties for Hemostasis and Wound Healing
The development of antibacterial sponges with both high water-absorbing and mechanical properties is highly desirable for attaining efficient hemostasis and closure of noncompressible wounds, but remains challenging. General methods, such as increasing porosity, to improve the water absorption of sponges inevitably compromise their mechanical properties. Herein, a chitin (CT)/quaternized chitosan (QCS) sponge with the desirable properties was fabricated by freeze-drying the chemically and physically dual cross-linked CT/QCS hydrogel with enhanced hydrophilicity. The obtained CT/QCS sponge possessed improved water (5906%) and blood absorption rates (6374%), robust mechanical strength (compressive stress at 90% strain = 0.52 MPa), and rapid water-triggered shape recovery ability (less than 5.3 s). In addition to good biocompatibility, the CT/QCS sponge also showed high in vitro/in vivo hemostatic efficacy and remarkable bacteriostasis rates against E. coli (85.4%) and S. aureus (91.6%) due to its hydrophilic and positively charged porous structure. The CT/QCS sponge exhibited significant healing efficacy in infected wounds compared to commercial gauze and gelatin sponge. This work demonstrates that the antibacterial CT/QCS sponge with enhanced water-absorbing and mechanical properties is promising for treating noncompressible bleeding and infected wounds.
- 11 March 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (11) , 7546-7558
Antibacterial Chitin-Based Sponges with Enhanced Water Absorbency and Mechanical Properties for Hemostasis and Wound Healing
The development of antibacterial sponges with both high water-absorbing and mechanical properties is highly desirable for attaining efficient hemostasis and closure of noncompressible wounds, but remains challenging. General methods, such as increasing porosity, to improve the water absorption of sponges inevitably compromise their mechanical properties. Herein, a chitin (CT)/quaternized chitosan (QCS) sponge with the desirable properties was fabricated by freeze-drying the chemically and physically dual cross-linked CT/QCS hydrogel with enhanced hydrophilicity. The obtained CT/QCS sponge possessed improved water (5906%) and blood absorption rates (6374%), robust mechanical strength (compressive stress at 90% strain = 0.52 MPa), and rapid water-triggered shape recovery ability (less than 5.3 s). In addition to good biocompatibility, the CT/QCS sponge also showed high in vitro/in vivo hemostatic efficacy and remarkable bacteriostasis rates against E. coli (85.4%) and S. aureus (91.6%) due to its hydrophilic and positively charged porous structure. The CT/QCS sponge exhibited significant healing efficacy in infected wounds compared to commercial gauze and gelatin sponge. This work demonstrates that the antibacterial CT/QCS sponge with enhanced water-absorbing and mechanical properties is promising for treating noncompressible bleeding and infected wounds.
- 7 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 6 (16) , 9960-9973
pH/Temperature Dual-Sensitive Hydrogel Based on Carboxymethyl Chitosan and a Pluronic for Combined Chemo-Photothermal Therapy
- 7 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 6 (16) , 9960-9973
pH/Temperature Dual-Sensitive Hydrogel Based on Carboxymethyl Chitosan and a Pluronic for Combined Chemo-Photothermal Therapy
- 25 April 2024
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 7 (9) , 10419-10428
pH-Sensitive Nanodrug Self-Assembled from Aliphatic 5-Fluorouracil Derivative and Doxorubicin for Synergistic Cancer Therapy
- 25 April 2024
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 7 (9) , 10419-10428
pH-Sensitive Nanodrug Self-Assembled from Aliphatic 5-Fluorouracil Derivative and Doxorubicin for Synergistic Cancer Therapy